Mouse anti Human CD56, conjugated with FITCCatalog number: 0562
CD56, M.W. 150,000, is expressed on approximately 10-25% of human peripheral blood lymphocytes. CD56 (NKH-1) is expressed on human peripheral blood natural killer cells, representing a pan NK-cell antigen. Expressed on non-MHC-restricted cytotoxic T cells.
Synonyms: CD56 FITC, NCAM, Neural Cell Adhesion Molecule
Derived from the hybridization of mouse Sp2/0 myeloma cells with spleen cells from BALB/c F1 mice immunized with KG1a cell line.
Provided as solution in phosphate buffered saline with 0.08% sodium azide and 0.2% carrier protein
Product Form: FITC
Concentration: Titered for flow cytometry
PBMC: Add10 µl of MAB/10^6 PBMC in 100 µl PBS. Mix gently and incubate for 15 minutes at 2° to 8° C. Wash twice with PBS and analyze or fix with 0.5% v/v of paraformaldehyde in PBS and analyze. WHOLE BLOOD: Add10 µl of MAB/100 µl of whole blood. Mix gently and incubate for 15 minutes at room temperature 20°C. Lyse the whole blood. Wash once with PBS and analyze or fix with 0.5% v/v of paraformaldehyde in PBS and analyze. See instrument manufacturer’s instructions for Lysed Whole Blood and Immunofluorescence analysis with a flow cytometer or microscope.
Functional Analysis: Flow Cytometry Staining
Product should be stored at 4-8°C. DO NOT FREEZE
Product Stability: See expiration date on vial
Shipping Conditions: Ship at ambient temperature
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Exalpha Biologicals accepts no liability for any inaccuracies or omissions in this information.
1. Generation of Monoclonal Antibodies to a Human Natural Killer Clone. Characterization of Two Natural Killer-Associated Antigens, NKH1 and NKH2, Expressed on Subset of Large Granular Lymphocytes. Hercend, T., Griffin, J.D., Benussan, A., Schmidt, R.E., Edson, M.A., Brennen, A., Murray, C., Daley, J.F., Schlossman, S.F., and Ritz, J.. J. Clin. Invest. 1985 75:932. 2. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) Antigen Expression on Human Peripheral Blood Nk Cells and Cytotoxic T Lymphocytes. Lanier, L.L., Le, A.M., Civin, C.I., Loken, M.R., and Phillips, J.H., J. Immunol. 1986 136,4480. 3. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. Schmidt RE, Murray C, Daley JF, Schlossman SF, and Ritz J, J Ex Med 1986 164: 351-356 4. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL, and Ritz J, J Immunol 1987 139:3306-3319 5. Hercend T., and Schmidt, R.E., Immunol. Today 9,291,1988.
Database Name: UniProt
Accession Number: P13591
Safety Datasheet(s) for this product: